The antiglycation activities of 2-(morpholin-4-yl)-1-(propen-2-en-1-yl)-1H-benzimidazole and 2-(morpholin-4-yl)-1-[2-(morpholin-4-yl)ethyl]-1H-benzimidazole were comparable to that of aminoguanidine. Some compounds exhibited moderate antiserotonin, anti-angiotensin, antioxidant, and dipeptidyl peptidase-4 (DPP-4) inhibitory effects.
合成了一系列含有2-
吡咯烷甲基和2-
哌嗪甲基以及2-吗啉代和2-吗啉代
乙胺取代基的新化合物。2-(morpholin-4-yl)-1-(propen-2-en-1-yl)-1H-
苯并咪唑和2-(morpholin-4-yl)-1-[2-(morpholin- 4-基)乙基]-1H-
苯并咪唑与
氨基
胍相当。一些化合物表现出中等的抗
血清素、抗
血管紧张素、抗氧化和二肽基肽酶 4 (
DPP-4) 抑制作用。